DOW vs. DD: Which Chemical Giant Deserves a Spot in Your Portfolio?

A comparative analysis suggests DuPont (DD) holds a slight investment edge over Dow (DOW) in the current market. While Dow is implementing cost-cutting measures and focusing on high-return projects, it faces demand softness and pricing pressures, leading to a 29.4% year-to-date stock decline and a high forward earnings multiple of 45.80. DuPont, benefiting from innovation and strategic acquisitions, faces headwinds from construction market weakness and separation costs, but its more attractive valuation and positive earnings growth projections give it an advantage, despite EPS estimates trending slightly downward.

Analysis

The chemical sector is currently navigating a challenging environment characterized by demand headwinds and tariff-related disruptions, impacting major players like Dow Inc. (DOW) and DuPont de Nemours, Inc. (DD), which carry Zacks Ranks of #4 (Sell) and #3 (Hold) respectively. Dow is proactively addressing these challenges through significant cost-cutting measures, including a $1 billion initiative with a planned 1,500 workforce reduction, and aims to generate $6 billion in cash support via asset sales and reduced capital expenditures, such as delaying its Fort Saskatchewan Path2Zero project. Despite these efforts and a strong Q1 liquidity of over $11 billion and an attractive 9.7% dividend yield, DOW faces considerable headwinds from demand softness in Europe, particularly in infrastructure and automotive sectors, and persistent siloxane pricing pressure. Its stock has declined 29.4% year-to-date, and it trades at a high forward P/E of 45.80, with Zacks Consensus Estimates for 2025 projecting a 3.1% sales decline and an 80.7% EPS drop, and its 2025 EPS estimates trending lower. Conversely, DuPont is focusing on innovation and strategic acquisitions in high-growth areas like healthcare, exemplified by the Spectrum Plastics and Donatelle Plastics buyouts, and is implementing its own cost-saving measures, targeting $150 million in annualized savings. DuPont's stock has fallen 10.7% year-to-date, outperforming DOW and the industry average decline of 15.6%, and it trades at a more favorable forward P/E of 15.45. While DD anticipates 2.9% sales growth and 4.9% EPS growth in 2025, its 2025 EPS estimates have also been trending southward. DuPont additionally contends with weakness in construction and automotive markets and faces substantial separation costs (modestly below $700 million, mostly in 2025) related to its electronics business, which are expected to impact margins and reduce its 2025 free cash flow conversion to above 90% from 105% in 2024. DuPont's comparatively better valuation, positive projected year-over-year growth for 2025, an 8% dividend increase, and a 7.1% five-year annualized dividend growth rate suggest it may offer a more compelling investment than DOW in the current market.

Key Decisions for Investors

• Investors considering Dow (DOW) should carefully weigh its substantial 9.7% dividend yield and aggressive cost-reduction efforts against prevailing demand softness in key markets, significant siloxane pricing pressure, a high forward P/E of 45.80, and a projected 80.7% EPS decline in 2025, warranting a cautious approach consistent with its Zacks Rank #4 (Sell).
• DuPont (DD), with a Zacks Rank #3 (Hold), presents a potentially more attractive investment case due to its lower forward P/E of 15.45, projected 2025 sales and EPS growth of 2.9% and 4.9% respectively, and strategic focus on high-growth healthcare markets, though investors must monitor the impact of its substantial upcoming electronics business separation costs and ongoing weakness in its industrial end markets.
• Given the challenging chemical industry landscape marked by tariff impacts and demand softness, investors should scrutinize ongoing macroeconomic indicators affecting both companies, particularly in Europe and key sectors like construction and automotive, and consider the distinct risk-reward profiles and downward trending EPS estimates before making allocation decisions.